Business Category
Investment Status
Active
Jim Gunton
Managing Partner
CytoSorbents (OTCBB:CTSO) is a publicly traded medical device company that has developed CytoSorb, a patented technology designed to treat potentially fatal “cytokine storm,” also known as sepsis.